Cystografin
Active substance: diatrizoate meglumine
INJECTION, SOLUTION · DIATRIZOATE MEGLUMINE 300 mg/mL
United StatesActive
Marketing holder: BRACCO DIAGNOSTICS INC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- DIATRIZOATE MEGLUMINE · 300 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12094-1597-772c-b2b0-212766fa51b2,01a1209b-81ca-7a1a-a3eb-e21e91693890;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0270-0149
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0270-0149 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0270-0149 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0270-0149 · Verified 2026-10-09 · open in source